Eli Lilly backs U.S. proposal on drug rebates to lower costs

Eli Lilly and Co on Wednesday embraced a U.S. government proposal to end a decades-old system of rebates drugmakers make to industry middlemen, saying it could lower the cost of insulin and other prescription drugs for patients.

Source: Reuters: Health - February 6, 2019 Category: Consumer Health News Tags: healthNews Source Type: news